Among the more remarkable legacies of the COVID-19 pandemic is how quickly federal regulators, the health care industry and consumers moved to make at-home testing a reliable tool for managing a public health crisis. But that fast-track focus is missing from another, less publicized epidemic: an explosion in sexually transmitted diseases that can cause chronic pain and infertility among .
The popularity of at-home COVID tests has amplified calls from health researchers and diagnostic companies to make testing similarly routine for sexually transmitted diseases. But FDA guidelines are lagging.
With little focus on the explosion of sexually transmitted diseases, companies are moving to market at-home test kits to target more Americans. Are they.
With little focus on the explosion of sexually transmitted diseases, companies are moving to market at-home test kits to target more Americans. Are they.
With little focus on the explosion of sexually transmitted diseases, companies are moving to market at-home test kits to target more Americans. Are they.